Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

Cited by (1,006)

Items 301–400 of 1,006

1. Enhancing Agriculture Through AI Vision and Machine Learning
   Mrutyunjay Padhiary, Raushan Kumar · 2024 · Advances in computational intelligence and robotics book series
2. Clinical characteristics and outcomes of COVID-19 patients admitted to the intensive care unit during the first year of the pandemic in Brazil: a single center retrospective cohort study
   Thiago Domingos Corrêa, Thais Dias Midega, Karina Tavares Timenetsky, Ricardo Luiz Cordioli, Carmen Sílvia Valente Barbas, Moacyr Silva, Bruno de Arruda Bravim, Bruno Caldin da Silva, Gustavo Faissol Janot de Matos, Ricardo Kenji Nawa et al. · 2021 · Einstein (São Paulo)
3. Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China
   Hengcong Liu, Juanjuan Zhang, Jun Cai, Xiaowei Deng, Cheng Peng, Xinghui Chen, Juan Yang, Qianhui Wu, Xinhua Chen, Zhiyuan Chen et al. · 2022 · BMC Medicine
4. The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape
   Darren P Martin, Steven Weaver, Houryiah Tegally, Emmanuel James San, Stephen D. Shank, Eduan Wilkinson, Alexander G. Lucaci, Jennifer Giandhari, Sureshnee Naidoo, Yeshnee Pillay et al. · 2021 · PubMed
5. COVID-19 deaths and hospitalizations averted by rapid vaccination rollout in the United States
   Seyed M. Moghadas, Pratha Sah, Meagan C. Fitzpatrick, Affan Shoukat, Abhishek Pandey, THOMAS NOGUEIRA VILCHES, Burton H. Singer, Eric C. Schneider, Alison P. Galvani · 2021 · medRxiv
6. A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern
   Matheus Filgueira Bezerra, Laís Ceschini Machado, Viviane do Carmo Vasconcelos de Carvalho, Cássia Docena, Sinval Pinto Brandão-Filho, Constância Flávia Junqueira Ayres, Marcelo Henrique Santos Paiva, Gabriel Luz Wallau · 2021 · Infection Genetics and Evolution
7. Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2
   Marta Giovanetti, Francesco Branda, Eleonora Cella, Fabio Scarpa, Liliana Bazzani, Alessandra Ciccozzi, Svetoslav Nanev Slavov, Domenico Benvenuto, Daria Sanna, Marco Casu et al. · 2023 · Journal of Medical Virology
8. Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor‐binding domain mutations: Receptor affinity versus neutralization of receptor interaction
   Monique Vogel, Gilles Sousa Augusto, Xinyue Chang, Xuelan Liu, Daniel E. Speiser, Mona Omar Mohsen, Martin F. Bachmann · 2021 · Allergy
9. Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology
   Jamie M. Caldwell, Xuan Le, Lorin McIntosh, Michael T. Meehan, Samson T. Ogunlade, Romain R. Ragonnet, Genevieve K. O’Neill, James McCracken Trauer, Emma Sue McBryde · 2021 · Paediatric Respiratory Reviews
10. Epidemiological dynamics of SARS-CoV-2 VOC Gamma in Rio de Janeiro, Brazil
    Filipe Romero Rebello Moreira, Mirela D’arc, Diana Mariani, Alice Laschuk Herlinger, Francine Bittencourt Schiffler, Átila Duque Rossi, Isabela de Carvalho Leitão, Thamiris dos Santos Miranda, Matheus Augusto Calvano Cosentino, Marcelo Calado de Paula Tôrres et al. · 2021 · Virus Evolution
11. Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency
    Luís Eduardo Ribeiro da Cunha, Adilson A. Stolet, Marcelo A. Strauch, Victor A. R. Pereira, Carlos Henrique Dumard, Andre M. O. Gomes, Fábio Luís Lima Monteiro, Luiza M. Higa, Patrícia N. C. Souza, Juliana Garcia da Silva Fonseca et al. · 2021 · iScience
12. VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
    Wasim Aluísio Prates-Syed, Lorena C. S. Chaves, Karin P. Crema, Larissa Vuitika, Aline Aparecida de Lima Lira, Nelson Côrtes, Victor Kersten, Francisco Eduardo Gontijo Guimarães, Mohammad Sadraeian, Fernando Luís Barroso da Silva et al. · 2021 · Vaccines
13. Viral Load in COVID-19 Patients: Implications for Prognosis and Vaccine Efficacy in the Context of Emerging SARS-CoV-2 Variants
    Severino Jefferson Ribeiro da Silva, Suelen Cristina de Lima, Ronaldo Celerino da Silva, Alain Kohl, Lindomar Pena · 2022 · Frontiers in Medicine
14. Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil
    Carlos Augusto Prete Junior, Lewis Buss, Renata Buccheri, Claudia M. M. Abrahim, Tassila Salomon, Myuki Alfaia Esashika Crispim, Márcio K. Oikawa, Eduard Grebe, Allyson Guimarães Costa, Nelson Abrahim Fraiji et al. · 2022 · BMC Infectious Diseases
15. Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
    Jonathan L. Torres, Gabriel Ozorowski, Emanuele Andreano, Hejun Liu, Jeffrey Copps, Giulia Piccini, Lorena Donnici, Matteo Conti, Cyril Planchais, Delphine Planas et al. · 2022 · Proceedings of the National Academy of Sciences
16. SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells
    Rayhane Nchioua, Annika Schundner, Dorota Kmieć, Caterina Prelli Bozzo, Fabian Zech, Lennart Koepke, Alexander Graf, Stefan Krebs, Helmut Blum, Manfred Frick et al. · 2022 · Journal of Virology
17. Genomic epidemiology of the first two waves of SARS-CoV-2 in Canada
    Angela McLaughlin, Vincent Montoya, Rachel L. Miller, Gideon J. Mordecai, Michael Worobey, Art F. Y. Poon, Jeffrey B. Joy · 2022 · eLife
18. COVID-19 in Latin America: A Snapshot in Time and the Road Ahead
    J LaRotta, Omar Escobar, María Luisa Avila-Aguero, Juan Pablo Torres, Rodrigo Sini de Almeida, Graciela del Carmen Morales, Amit K. Srivastava · 2023 · Infectious Diseases and Therapy
19. CESSAT: A chemical additive-enhanced single-step accurate CRISPR/Cas13 testing system for field-deployable ultrasensitive detection and genotyping of SARS-CoV-2 variants of concern
    Yunxiang Wang, Hong Chen, Huixia Gao, Hongjuan Wei, Yuling Wang, Kai Mu, Liyan Liu, Erhei Dai, Zhen Rong, Shengqi Wang · 2023 · Biosensors and Bioelectronics
20. Clinical metagenomics for diagnosis and surveillance of viral pathogens
    Oscar Enrique Torres Montaguth, Sarah Buddle, Sofia Morfopoulou, Judith Breuer · 2025 · Nature Reviews Microbiology
21. Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
    Laura Di Domenico, Chiara E. Sabbatini, Giulia Pullano, Daniel Lévy-Bruhl, Vittoria Colizza · 2021 · Eurosurveillance
22. SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil
    Camila Malta Romano, Alvina Clara Félix, Anderson Vicente de Paula, Jaqueline Góes de Jesus, Pâmela dos Santos Andrade, Darlan da Silva Cândido, Franciane Mendes de Oliveira, Andreia C. Ribeiro, Francini C. da Silva, Marta Inemami et al. · 2021 · Revista do Instituto de Medicina Tropical de São Paulo
23. Attitudes towards the COVID-19 Vaccine and Willingness to Get Vaccinated among Healthcare Workers in French Guiana: The Influence of Geographical Origin
    Nicolas Vignier, Kepha Brureau, S. Granier, Jacques Breton, Céline Michaud, Mélanie Gaillet, Camille Agostini, Mathilde Ballet, Mathieu Nacher, Audrey Valdes et al. · 2021 · Vaccines
24. The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice
    Rafael Bayarri‐Olmos, Laust Bruun Johnsen, Manja Idorn, Line Sinnathamby Reinert, Anne Rosbjerg, Søren Vang, Cecilie Bo Hansen, Charlotte Helgstrand, Jais Rose Bjelke, Theresa Bak-Thomsen et al. · 2021 · eLife
25. Perceptions of Critical Care Shortages, Resource Use, and Provider Well-being During the COVID-19 Pandemic
    Suzana M. Lobo, Claire J. Creutzfeldt, Israel Silva Maia, James A. Town, Edilberto Amorim, Erin K. Kross, Başak Çoruh, Pratik V. Patel, Gemi E. Jannotta, Ariane K. Lewis et al. · 2022 · CHEST Journal
26. Unusual SARS-CoV-2 intrahost diversity reveals lineage superinfection
    Filipe Zimmer Dezordi, Paola Cristina Resende, Felipe Gomes Naveca, Valdinete Alves do Nascimento, Victor Costa de Souza, Anna Carolina Dias Paixão, Luciana Appolinario, Renata Serrano Lopes, Ana Carolina da Fonseca Mendonça, Alice Sampaio Barreto da Rocha et al. · 2022 · Microbial Genomics
27. Investigating the evolutionary origins of the first three SARS-CoV-2 variants of concern
    Mahan Ghafari, Qihan Liu, Arushi Dhillon, Aris Katzourakis, Daniel B. Weissman · 2022 · Frontiers in Virology
28. SARS-CoV-2 variants: Impact on biological and clinical outcome
    Shakuntala Mahilkar, Sachee R Agrawal, Sakshi Chaudhary, Swapneil Parikh, Subash Chandra Sonkar, Dileep Kumar Verma, Vidushi Chitalia, Divya Mehta, Bidhan Chandra Koner, Neetu Vijay et al. · 2022 · Frontiers in Medicine
29. COVID-19: Epidemiologie und Mutationen
    Christoph Josef Hemmer, Micha Löbermann, Emil Christian Reisinger · 2021 · Der Radiologe
30. COVID-19: vaccines, efficacy and effects on variants
    Igor Rudan, Davies Adeloye, Aziz Sheikh · 2022 · Current Opinion in Pulmonary Medicine
31. The Immune Response to SARS-CoV-2 and Variants of Concern
    Elham Torbati, Kurt L. Krause, James E. Ussher · 2021 · Viruses
32. Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil
    Alessandra Pavan Lamarca, Luiz Gonzaga Paula de Almeida, Ronaldo da Silva Francisco, Lucymara Fassarella Agnez‐Lima, Kátia Castanho Scortecci, Vinícius Pietta Perez, Otávio J. B. Brustolini, Eduardo Sérgio Soares Sousa, Danielle Secco, Ângela Santos et al. · 2021 · PLoS neglected tropical diseases
33. Genome Sequencing of SARS-CoV-2 Allows Monitoring of Variants of Concern through Wastewater
    Malte Herold, Aymeric Fouquier d’Hérouël, Patrick May, Francesco Delogu, Anke K. Wienecke-Baldacchino, Jessica Tapp, Cécile Walczak, Paul Wilmes, Henry‐Michel Cauchie, Guillaume Fournier et al. · 2021 · Water
34. The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines
    Yao Jiang, Qian Yun Wu, Peipei Song, Chongge You · 2022 · Frontiers in Medicine
35. Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern
    Tiago Gräf, Gonzalo Bello, Tainá Moreira Martins Venas, Elisa Cavalcante Pereira, Anna Carolina Dias Paixão, Luciana Appolinario, Renata Serrano Lopes, Ana Carolina da Fonseca Mendonça, Alice Sampaio Barreto da Rocha, Fernando Couto Motta et al. · 2021 · Virus Evolution
36. Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021
    Paola Stefanelli, Filippo Trentini, Giorgio Dirani, Valentina Marziano, Alessia Mammone, Piero Poletti, Carla Molina Grané, Mattia Manica, Martina Del Manso, Xanthi D. Andrianou et al. · 2022 · Eurosurveillance
37. The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic
    Maria Karoliny da Silva Torres, Carlos David Araújo Bichara, Maria de Nazaré do Socorro de Almeida, Mariana Cayres Vallinoto, Maria Alice Freitas Queiroz, Izaura Maria Vieira Cayres Vallinoto, Eduardo José Melo dos Santos, Carlos Alberto Marques de Carvalho, Antônio Carlos Rosário Vallinoto · 2022 · Frontiers in Microbiology
38. Neutralizing antibodies to SARS‐CoV‐2 variants of concern including Delta and Omicron in subjects receiving mRNA‐1273, BNT162b2, and Ad26.COV2.S vaccines
    George Fei Zhang, Wen Meng, Luping Chen, Ling Ding, Jian Feng, Joseph Pérez, Abid Ali, Shenyu Sun, Zhentao Liu, Yufei Huang et al. · 2022 · Journal of Medical Virology
39. SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo
    Emi E. Nakayama, Tatsuo Shioda · 2023 · Microorganisms
40. Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
    Cody J. Bills, Hongjie Xia, John Yun-Chung Chen, Jason Yeung, Birte Kalveram, David Hughes Walker, Xuping Xie, Pei‐Yong Shi · 2023 · Emerging Microbes & Infections
41. Comparison of the First and Second Waves of the Coronavirus Disease 2019 Pandemic in Children and Adolescents in a Middle-Income Country: Clinical Impact Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Gamma Lineage
    Eduardo Araujo OLIVEIRA, Ana Cristina Simões e Silva, Maria Christina L. Oliveira, Enrico A. Colosimo, ROBERT H. K. MAK, Mariana Affonso Vasconcelos, Débora Marques de Miranda, Daniella Reis Barbosa Martelli, Ludmila R. Silva, Clara Catharino Pinhati et al. · 2022 · The Journal of Pediatrics
42. Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil
    Ricardo Ariel Zimerman, Patrícia Aline Gröhs Ferrareze, Flavio Cadegiani, Carlos Gustavo Wambier, Daniel do Nascimento Fonseca, Andrea Roberto de Souza, Andy Goren, Liane Nanci Rotta, Zhihua Ren, Claudia Elizabeth Thompson · 2022 · Frontiers in Medicine
43. Fitness models provide accurate short-term forecasts of SARS-CoV-2 variant frequency
    Eslam Abousamra, Marlin D Figgins, Trevor Bedford · 2024 · PLoS Computational Biology
44. Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease‐19 pandemic
    Jatin Chadha, Lavanya Khullar, Nidhi Mittal · 2021 · Environmental Microbiology
45. Monitoring the Circulation of SARS-CoV-2 Variants by Genomic Analysis of Wastewater in Marseille, South-East France
    Nathalie Wurtz, Océane Revol, Priscilla Jardot, Audrey Giraud‐Gatineau, Linda Houhamdi, Christophe Soumagnac, Alexandre Annessi, Alexandre Lacoste, Philippe Colson, Sarah Aherfi et al. · 2021 · Pathogens
46. Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants
    Yohei Seki, Yasuo Yoshihara, Kiyoko Nojima, Haruka Momose, Shuetsu Fukushi, Saya Moriyama, Ayumi Wagatsuma, Narumi Numata, Kyohei Sasaki, Tomoyo Kuzuoka et al. · 2022 · Med
47. The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico
    Selene Zárate, Blanca Taboada, José Esteban Muñoz‐Medina, Pavel Iša, Alejandro Sánchez‐Flores, Célia Boukadida, Alfredo Herrera‐Estrella, Nelly Selem Mojica, Mauricio Rosales-Rivera, Bruno Gómez‐Gil et al. · 2022 · Microbiology Spectrum
48. PARIS and SPARTA: Finding the Achilles’ Heel of SARS-CoV-2
    Viviana R. Simon, Vamsi K Kota, Ryan F. Bloomquist, Hannah B. Hanley, David Forgacs, Savita G. Pahwa, Suresh Pallikkuth, Loren Gregory Miller, Joanna M. D. Schaenman, Michael R. Yeaman et al. · 2022 · mSphere
49. Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences
    Dorota Kamińska, Dominika Dęborska−Materkowska, Katarzyna Kościelska−Kasprzak, Oktawia Mazanowska, Agata Remiorz, Paweł Poznański, Magdalena Durlik, Magdalena Krajewska · 2022 · Vaccines
50. Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
    Théophile Cocherie, Karen Zafilaza, Valentin Leducq, Stéphane Marot, Vincent Cálvez, Anne‐Geneviève Marcelin, Ève Todesco · 2022 · Microorganisms
51. Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile
    2022
52. Predicting the mutational drivers of future SARS-CoV-2 variants of concern
    M. Cyrus Maher, István Bartha, Steven Weaver, Julia di Iulio, Elena Ferri, Leah B. Soriaga, Florian A. Lempp, Brian Hie, Bryan D. Bryson, Bonnie Berger et al. · 2021 · DSpace@MIT (Massachusetts Institute of Technology)
53. Community-level SARS-CoV-2 sequence diversity revealed by wastewater sampling
    Candice L. Swift, Mirza Isanovic, Karlen E. Correa Velez, Robert Sean Norman · 2021 · The Science of The Total Environment
54. Pandemic moves and countermoves: vaccines and viral variants
    Rogier W. Sanders, Menno D. de Jong · 2021 · The Lancet
55. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model
    Kyle Lee O’Donnell, Amanda N. Pinski, Chad S. Clancy, Tylisha Gourdine, Kyle Shifflett, Paige Fletcher, Ilhem Messaoudi, Andrea Marzi · 2021 · EBioMedicine
56. Molecular Epidemiology of SARS-CoV-2 in Tunisia (North Africa) through Several Successive Waves of COVID-19
    Anissa Chouikha, Wasfi Farès, Asma Lamari, S Boubaker, Zeineb Belaiba, Kaïs Ghedira, Wafa Kammoun Rebai, Kaouther Ayouni, Marwa Khedhiri, Samar Ben Halima et al. · 2022 · Viruses
57. Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates
    Qian He, Qunying Mao, Xiaozhong Peng, Zhanlong He, Shuaiyao Lu, Jialu Zhang, Fan Gao, Lianlian Bian, Chaoqiang An, Wenhai Yu et al. · 2022 · Signal Transduction and Targeted Therapy
58. Alteration of prostaglandin production and agonist responsiveness by n-6 polyunsaturated fatty acids in endometrial cells from late-gestation ewes
    Zhangrui Cheng, Matthew J. Elmes, S E Kirkup, D.R.E. Abayasekara, D. Claire Wathes · 2004 · Journal of Endocrinology
59. Sudden rise in COVID-19 case fatality among young and middle-aged adults in the south of Brazil after identification of the novel B.1.1.28.1 (P.1) SARS-CoV-2 strain: analysis of data from the state of Parana
    Maria Helena Santos de Oliveira, Giuseppe Lippi, Brandon Michael Henry · 2021 · medRxiv
60. Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France
    Benjamin Lefèvre, Laura Tondeur, Yoann Madec, Rebecca Grant, Bruno Lina, Sylvie van der Werf, Christian Rabaud, Arnaud L Fontanet, Antoine Legoff · 2021 · The Lancet Healthy Longevity
61. Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2
    Mariana Soares da Silva, Meriane Demoliner, Alana Witt Hansen, Juliana Schons Gularte, Flávio Silveira, Fágner Henrique Heldt, Micheli Filippi, Vyctoria Malayhka de Abreu Góes Pereira, Francini Pereira da Silva, Larissa Mallmann et al. · 2021 · Revista do Instituto de Medicina Tropical de São Paulo
62. The variants question: What is the problem?
    Davide Zella, Marta Giovanetti, Francesca Benedetti, Francesco Unali, Silvia Spoto, Michele Pier Luca Guarino, Silvia Angeletti, Massimo Ciccozzi · 2021 · Journal of Medical Virology
63. Phylogenetic-based inference reveals distinct transmission dynamics of SARS-CoV-2 lineages Gamma and P.2 in Brazil
    Tiago Gräf, Gonzalo Bello, Felipe Gomes Naveca, Marcelo Ferreira da Costa Gomes, Vanessa Leiko Oikawa Cardoso, Alexandre Freitas da Silva, Filipe Zimmer Dezordi, Mirleide Cordeiro dos Santos, Katia Correa de Oliveira Santos, Érika Lopes Rocha Batista et al. · 2022 · iScience
64. Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host
    Francesca Caccuri, Serena Messali, Daria Bortolotti, Dario Di Silvestre, Antonella De Palma, Chiara M. Cattaneo, Anna Bertelli, Alberto Zani, Maria Milanesi, Marta Giovanetti et al. · 2022 · Virus Evolution
65. Structural understanding of SARS-CoV-2 virus entry to host cells
    Kim Phuong Uyen Le, Shrute Kannappan, Truc Kim, Jung Heon Lee, Hye-Ra Lee, Kyeong Kyu Kim · 2023 · Frontiers in Molecular Biosciences
66. Role of SARS-CoV-2 and ACE2 variations in COVID-19
    Priya Antony, Ranjit Vijayan · 2021 · Biomedical Journal
67. Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
    Eun-Jin Lee, Ji Eun Oh · 2021 · Molecules and Cells
68. A Next-Generation Vaccine Candidate Using Alternative Epitopes to Protect against Wuhan and All Significant Mutant Variants of SARS-CoV-2: An Immunoinformatics Approach
    Manojit Bhattacharya, Ashish Ranjan Sharma, Pratik Ghosh, Sang‐Soo Lee, Chiranjib Chakraborty · 2021 · Aging and Disease
69. Multi-scale modelling reveals that early super-spreader events are a likely contributor to novel variant predominance
    Ashish Goyal, Daniel B. Reeves, Joshua Tisdell Schiffer · 2022 · Journal of The Royal Society Interface
70. Human Development Index Is Associated with COVID-19 Case Fatality Rate in Brazil: An Ecological Study
    Camila Vantini Capasso Palamim, Matheus Negri Boschiero, Felipe Eduardo Valencise, Fernando Augusto Lima Marson · 2022 · International Journal of Environmental Research and Public Health
71. Customization of aptamer to develop CRISPR/Cas12a-derived ultrasensitive biosensor
    Wenping Xing, Qian Li, Cong Han, Dongdong Sun, Zheng Zhang, Xiaona Fang, Yu Guo, Feng Ge, Wei Ding, Zhaofeng Luo et al. · 2023 · Talanta
72. A tale of two variants: Spread of SARS-CoV-2 variants Alpha in Geneva, Switzerland, and Beta in South Africa
    Christian Lorenz Althaus, Stéphanie Baggio, Martina L. Reichmuth, Emma B. Hodcroft, Julien Riou, Richard A. Neher, Frédérique Jacquérioz, Hervé Spechbach, Julien Salamun, Pauline Vetter et al. · 2021 · medRxiv
73. Structure-activity relationships of B.1.617 and other SARS-CoV-2 spike variants
    Tzu‐Jing Yang, Pei‐Yu Yu, Yuan‐Chih Chang, Ning-En Chang, Yu-Xi Tsai, Kang-Hao Liang, Piotr Drączkowski, Bertina Lin, Yongsheng Wang, Yu-Chun Chien et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
74. SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines
    Xi Li, Ze Mi, Zhenguo Liu, Pengfei Rong · 2024 · Frontiers in Microbiology
75. The SARS-CoV-2 B.1.351 lineage (VOC β) is outgrowing the B.1.1.7 lineage (VOC α) in some French regions in April 2021
    Bénédicte Roquebert, Sabine Trombert‐Paolantoni, Stéphanie Haïm‐Boukobza, Emmanuel Lecorché, Laura Verdurme, Vincent Foulongne, Mircea T. Sofonea, Samuel Alizon · 2021 · Eurosurveillance
76. Adaptation of the endemic coronaviruses HCoV-OC43 and HCoV-229E to the human host
    Diego Forni, Rachele Cagliani, Federica Arrigoni, Martino Benvenuti, Alessandra Mozzi, Uberto Pozzoli, Mario Clerici, Luca DE GIOIA, Manuela Sironi · 2021 · Virus Evolution
77. Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations
    William M. Showers, Sonia M. Leach, Katerina J. Kechris, Michael Strong · 2021 · Infection Genetics and Evolution
78. Parental coronavirus disease vaccine hesitancy for children in Bangladesh: a cross-sectional study
    Mohammad Ali, Sohel M G Ahmed, Atia Sharmin Bonna, Abu-sufian Sarkar, Md. Ariful Islam, Tania Akter Urmi, Tasnuva Samarukh Proma · 2022 · F1000Research
79. Genomic Epidemiology of SARS-CoV-2 Divulge B.1, B.1.36, and B.1.1.7 as the Most Dominant Lineages in First, Second, and Third Wave of SARS-CoV-2 Infections in Pakistan
    Atia Basheer, Imran Zahoor · 2021 · Microorganisms
80. Challenges of vaccination and herd immunity in COVID‐19 and management strategies
    Jun She, Dongni Hou, Cuicui Chen, Jing Bi, Yuanlin Song · 2022 · The Clinical Respiratory Journal
81. A Glimpse on the Evolution of RNA Viruses: Implications and Lessons from SARS-CoV-2
    Petra Šimičić, Snježana Židovec Lepej · 2022 · Viruses
82. Structural basis for the inhibition of coronaviral main proteases by ensitrelvir
    Cheng‐Wen Lin, Haihai Jiang, Wenwen Li, Pei Zeng, Xuelan Zhou, Jin Zhang, Jian Li · 2023 · Structure
83. Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
    Günl, Franziska, Mecate-Zambrano, Angeles, Rehländer, Selina, Hinse, Saskia, Ludwig, Stephan, Brunotte, Linda · 2021 · Vaccines
84. Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil
    Cássia Fernanda Estofolete, Cecília Ártico Banho, Guilherme Rodrigues Fernandes Campos, Beatriz de Carvalho Marques, Lívia Sacchetto, Leila Sabrina Ullmann, Fábio Sossai Possebon, Luana Fernandes Machado, Juliana Devós Syrio, João Pessoa Araújo et al. · 2021 · Viruses
85. SARS‐CoV‐2 worldwide replication drives rapid rise and selection of mutations across the viral genome: a time‐course study – potential challenge for vaccines and therapies
    Stefanie Weber, Christina M. Ramirez, Barbara Weiser, Harold Burger, Walter Doerfler · 2021 · EMBO Molecular Medicine
86. Inferring variant-specific effective reproduction numbers from combined case and sequencing data
    Marlin D Figgins, Trevor Bedford · 2026 · eLife
87. Modeling the onset of symptoms of COVID-19: Effects of SARS-CoV-2 variant
    Joseph Larsen, Margaret R. Martin, John D. Martin, James B Hicks, Peter Kühn · 2021 · PLoS Computational Biology
88. Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant
    Naru Zhang, Qianting Ji, Zezhong Liu, Kaiming Tang, Yubin Xie, Kangchen Li, Jie Zhou, Sisi Li, Haotian Shang, Zecan Shi et al. · 2022 · Viruses
89. Variant‐specific SARS‐CoV‐2 within‐host kinetics
    Baptiste Elie, Bénédicte Roquebert, Mircea T. Sofonea, Sabine Trombert‐Paolantoni, Vincent Foulongne, Jérémie Guedj, S. Haïm-Boukobza, Samuel Alizon · 2022 · Journal of Medical Virology
90. Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
    Lianlian Bian, Jianyang Liu, Fan Gao, Qiushuang Gao, Qian He, Qunying Mao, Xing Wu, Miao Xu, Zhenglun Liang · 2022 · Human Vaccines & Immunotherapeutics
91. Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review
    Lei Zhao, Song Li, Wu Zhong · 2022 · Frontiers in Pharmacology
92. Identifying COVID-19 Severity-Related SARS-CoV-2 Mutation Using a Machine Learning Method
    FeiMing Huang, Lei Chen, Wei Guo, Xianchao Zhou, Kaiyan Feng, Tao Huang, Yu‐Dong Cai · 2022 · Life
93. Epidemiological characterization of SARS-CoV-2 variants in children over the four COVID-19 waves and correlation with clinical presentation
    Claudia Alteri, Rossana Scutari, Valentino Costabile, Luna Colagrossi, Katia Yu La Rosa, Emanuele Agolini, Valentina Lanari, Sara Chiurchiù, Lorenza Romani, Anna Hermine Markowich et al. · 2022 · Scientific Reports
94. Longitudinal single-cell analysis of SARS-CoV-2–reactive B cells uncovers persistence of early-formed, antigen-specific clones
    Lydia Scharf, Hannes Axelsson, Aikaterini Emmanouilidi, Nimitha R. Mathew, Daniel J. Sheward, Susannah Leach, Pauline Isakson, Ilya Valerevich Smirnov, Emelie Marklund, Nicolae Miron et al. · 2022 · JCI Insight
95. Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark
    Thomas Yssing Michaelsen, Marc Bennedbæk, Lasse Engbo Christiansen, Mia S. F. Jørgensen, Camilla Holten Møller, Emil Aarre Sørensen, Simon Knutsson, Jakob Brandt, Thomas Bygh Nymann Jensen, Clarisse Chiche-Lapierre et al. · 2022 · Genome Medicine
96. Interacting Epidemics in Amazonian Brazil: Prior Dengue Infection Associated With Increased Coronavirus Disease 2019 (COVID-19) Risk in a Population-Based Cohort Study
    Vanessa C. Nicolete, Priscila T. Rodrigues, Igor Cavallini Johansen, Rodrigo M. Corder, Juliana Tonini, Marly Augusto Cardoso, Jaqueline Góes de Jesus, Ingra Morales Claro, Nuno Rodrigues Faria, Éster Cerdeira Sabino et al. · 2021 · Clinical Infectious Diseases
97. Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants
    Austin N. Spratt, Saathvik R. Kannan, Lucas T. Woods, Gary A. Weisman, Thomas P. Quinn, Christian L. Lorson, Anders B. Sönnerborg, Siddappa N. Byrareddy, Kamal Deep Singh · 2021 · Computational and Structural Biotechnology Journal
98. Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteins
    Maryam Hojjat Jodaylami, Abdelhadi Djaïleb, Pierre Ricard, Étienne Lavallée, Stella Cellier-Goetghebeur, Megan-Faye Parker, Julien Coutu, Matthew Stuible, Christian Gervais, Yves Durocher et al. · 2021 · Scientific Reports
99. Rapid test to assess the escape of SARS-CoV-2 variants of concern
    Jacob T. Heggestad, Rhett J. Britton, David Kinnamon, Simone A. Wall, Daniel Y. Joh, Angus Hucknall, Lyra B. Olson, Jack G. Anderson, Anna Mazur, Cameron R. Wolfe et al. · 2021 · Science Advances
100. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters
     Yuki Takamatsu, Masaki Imai, Kenji Maeda, Noriko Nakajima, Nobuyo Higashi‐Kuwata, Kiyoko Iwatsuki‐Horimoto, Mutsumi Ito, Maki Kiso, Tadashi Maemura, Yuichiro Takeda et al. · 2021 · Journal of Virology